Related Experiment Video
Updated: Jul 9, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
[Antibiotic drug-resistant tuberculosis].
Ulf Greinert1, Doris Hillemann, Christoph Lange
1Klinische Infektiologie, Medizinische Klinik, Forschungszentrum Borstel. ugreinert@fz-borstel.de
Medizinische Klinik (Munich, Germany : 1983)
|December 14, 2007
Summary
Tuberculosis drug resistance is a growing global health threat. Effective treatment for multidrug-resistant tuberculosis (MDR-TB) requires tailored antibiotic combinations and experienced medical guidance.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Tuberculosis (TB) remains a major global infectious disease, with approximately 9 million new cases annually.
- Antibiotic drug resistance in Mycobacterium tuberculosis is a significant and increasing challenge.
- Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are emerging worldwide.
Purpose of the Study:
- To highlight the challenges posed by drug-resistant tuberculosis.
- To emphasize the necessity of appropriate treatment strategies for MDR-TB.
- To underscore the importance of physician expertise in managing MDR-TB.
Main Methods:
- Review of current literature on tuberculosis drug resistance.
- Analysis of treatment guidelines for MDR-TB.
- Discussion of challenges in MDR-TB patient management.
Main Results:
- MDR-TB requires combination therapy with 4-6 alternative drugs based on in vitro susceptibility testing.
- Treatment for MDR-TB is prolonged (18 months post-culture negativity) and costly.
- Adverse effects are common, necessitating experienced physician supervision.
Conclusions:
- Drug resistance in tuberculosis presents a critical public health issue.
- Management of MDR-TB demands specialized knowledge and careful therapeutic selection.
- Patient adherence and physician experience are crucial for successful MDR-TB treatment outcomes.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
00:57Antibiotic Selection
Overview
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...